Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
EP1.01 - Advanced NSCLC
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
EP1.01-24 - Lung Adenocarcinoma: Mutational Profile in Ever Smokers and Non-Smokers Patients
08:00 - 08:00 | Presenter: Daniel Oliveira Reis | Author(s): Catarina Marques, Daniel Coutinho, Eloísa Silva, Margarida Dias, Telma Costa, Sérgio Campainha, Sara Conde, Luís Cirnes, Ana Barroso
- Abstract
Loading... -
+
EP1.01-80 - Progressive Disease with T790M Mutation vs Non-T790M Mutation in EGFR Positive Patients Treated with Tyrosine Kinase Inhibitors
08:00 - 08:00 | Presenter: Daniel Oliveira Reis | Author(s): Nuno China, Margarida Dias, Daniel Coutinho, Eloísa Silva, Sérgio Campainha, Telma Costa, Sara Conde, Luís Cirnes, Ana Barroso
- Abstract
Loading...
-
+
EP1.04 - Immuno-oncology
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
EP1.04-10 - Nivolumab in Non-Small Cell Lung Cancer (NSCLC): A Real-Life Study
08:00 - 08:00 | Presenter: Daniel Oliveira Reis | Author(s): Aurora Mendes, Nuno China, Margarida Dias, Daniel Coutinho, Eloísa Silva, Sérgio Campainha, Telma Costa, Sara Conde, Ana Barroso
- Abstract
Loading...
-
+
EP1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
EP1.16-16 - Pembrolizumab as First Therapeutic Line in Non-Small Cell Lung Cancer – The Experience of a Portuguese Tertiary Hospital
08:00 - 08:00 | Presenter: Nuno Filipe Teixeira China Pereira | Author(s): Aurora Mendes, Daniel Oliveira Reis, Margarida Dias, Daniel Coutinho, Telma Costa, Eloísa Silva, Sérgio Campainha, Sara Conde, Ana Barroso
- Abstract
Loading... -
+
EP1.16-20 - Pembrolizumab - Subsequent Lines in Non-Small Cell Lung Cancer: The Experience of a Tertiary Hospital
08:00 - 08:00 | Presenter: Nuno Filipe Teixeira China Pereira | Author(s): Aurora Mendes, Daniel Oliveira Reis, Margarida Dias, Daniel Coutinho, Telma Costa, Eloísa Silva, Sérgio Campainha, Sara Conde, Ana Barroso
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-30 - Pioneer Study: Precision Immuno-Oncology for Advanced Non-Small Cell Lung Cancer Patients with PD1/L1 ICI Resistance
09:45 - 09:45 | Presenter: Fabrice Barlesi | Author(s): David Pérol, Julien Mazieres, Maurice Perol, Nathalie Varoqueaux, Florence Monville, Clarisse Audigier-Valette, Patricia Barre, François Domergue, Lionel Falchero, Cyril Foa, Ahmed Frikha, Stéphane Hominal, Jacques Le Treut, Sarah Zahi, Marie Roumieux, Daniel Olive, Eric Vivier
- Abstract
Loading... -
+
P1.04-33 - Deep Phenotyping of Immune Populations Reveals Baseline Predictors of Pembrolizumab Efficacy in NSCLC on KEYNOTE-001
09:45 - 09:45 | Presenter: Philippe Rochigneux | Author(s): Aaron Lisberg, Alejandro Garcia, Anne Sophie Chretien, Stephane Fattori, Anne Madroszyk, Alan Tseng, Wisdom Akingbemi, Jaklin Gukasyan, John Madrigal, James Carroll, Zorawar Noor, Amy Lauren Cummings, Daniel Olive, Edward Garon
- Abstract
Loading... -
+
P1.04-61 - Neutrophil-Lymphocyte Ratio: A Predictive Biomarker of Immunotherapy in Lung Cancer?
09:45 - 09:45 | Presenter: Nuno China | Author(s): Maria Aurora Mendes, Daniel Oliveira Reis, Sérgio Campainha, Margarida Dias, Ana Barroso
- Abstract
Loading...